The results of SOM clustering. حسب Jeong-Soo Gim (18058588)

NGS datasets recovered from stomach contents of <i>E. erythropterus</i> in the NRE. حسب Jeong-Soo Gim (18058588)

Differentially-expressed NLR genes in susceptible T200 and tolerant TME3 genotypes infected with SACMV. حسب Bulelani L. Sizani (21485746)

Characteristics of the participants. حسب Kazuhiro Suzuki (160528)

"…Among the 109 participants (12 with schizophrenia, 55 with mood disorders, 34 with anxiety disorders, and 8 with other conditions), a significant reduction in psychological distress was observed after the guideline relaxation (Cohen’s d = 0.344, p < 0.01). …"

Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR). حسب Bulelani L. Sizani (21485746)

Participant demographic and clinical characteristics. حسب Claire M. Douglas (21238238)

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. حسب Claire M. Douglas (21238238)

Diverse regulatory gate forms. حسب Jeong-Soo Gim (18058588)

The results of self-organising map (SOM) clustering. حسب Jeong-Soo Gim (18058588)

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

Description of the study sites in the NRE. حسب Jeong-Soo Gim (18058588)

Correlation analysis of red blood cell-platelet ratio and coagulation indicators. حسب Jie Zhao (49409)

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. حسب Jie Zhao (49409)

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... حسب Claire M. Douglas (21238238)

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. حسب Jie Zhao (49409)

CONSORT flow diagram depicting participant flow through the trial. حسب Leigh V. Evans (19753987)

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... حسب Claire M. Douglas (21238238)

Total count of HiFi reads indicating gene variation in 24 cassava genotypes. حسب Bulelani L. Sizani (21485746)

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)